StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.17−0.05 (-4.10%)

Close on Nov 18, 2026Market cap $39.95MP/E –Yield –

CalciMedica shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

CalciMedica's shares outstanding was 17M at Jun 30, 2026. For fiscal 2025 it was 15M, up 33.5% from the year before. The highest annual figure on record is 21M in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202515M+33.5%
FY2024Dec 31, 202411M+150.7%
FY2023Dec 31, 20234M+5354.7%
FY2022Dec 31, 20220M-99.6%
FY2021Dec 31, 202121M+220.3%
FY2020Dec 31, 20207M+401.4%
FY2019Dec 31, 20191M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202617M+14.0%
Q1 FY2026Mar 31, 202616M+15.6%
Q4 FY2025Dec 31, 202516M+22.2%
Q3 FY2025Sep 30, 202515M+35.4%
Q2 FY2025Jun 30, 202515M+34.7%
Q1 FY2025Mar 31, 202514M+40.5%
Q4 FY2024Dec 31, 202413M+125.8%
Q3 FY2024Sep 30, 202411M+96.5%
Q2 FY2024Jun 30, 202411M+96.6%
Q1 FY2024Mar 31, 202410M+1120.7%
Q4 FY2023Dec 31, 20236M+6821.4%
Q3 FY2023Sep 30, 20236M+7103.2%
Q2 FY2023Jun 30, 20236M-73.5%
Q1 FY2023Mar 31, 20231M-96.1%
Q2 FY2022Jun 30, 20220M-99.6%
Q1 FY2022Mar 31, 20220M-99.6%
Q4 FY2021Dec 31, 202121M+657.1%
Q3 FY2021Sep 30, 202121M+1443.0%
Q2 FY2021Jun 30, 202121M+1437.9%
Q1 FY2021Mar 31, 202121M+1432.6%
Q3 FY2020Sep 30, 20203M+113.9%
Q2 FY2020Jun 30, 20201M–
Q1 FY2020Mar 31, 20201M–
Q4 FY2019Dec 31, 20191M–
Q3 FY2019Sep 30, 20191M–

More CalciMedica figures

See a number that looks wrong?